Dolutegravir 25 mg and 50 mg and Griseofulvin Microsize Oral Suspension
Determining the interaction of Dolutegravir 25 mg and 50 mg and Griseofulvin Microsize Oral Suspension and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Coadministration with inducers of UGT1A and CYP450 3A4 isoenzymes may decrease the plasma concentrations of dolutegravir, which is primarily metabolized by UGT1A1 with some contribution from CYP450 3A4. Dolutegravir is also a substrate of UGT1A3, UGT1A9, and P-glycoprotein in vitro. In 9 study subjects, administration of dolutegravir 50 mg once daily with rifabutin 300 mg once daily decreased dolutegravir trough plasma concentration (Cmin; 24 hours postdose) by 30% compared to administration without rifabutin. The clinical significance is unknown. Given the risk of reduced viral susceptibility and resistance development associated with subtherapeutic antiretroviral drug levels, caution may be advisable if dolutegravir is used in combination with mild or moderate UGT1A/CYP450 3A4 inducers.
- "Product Information. Tivicay (dolutegravir)." ViiV Healthcare, Research Triangle Park, NC.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: griseofulvin
Brand name: Grifulvin V, Fulvicin P/G, Fulvicin U/F, Gris-PEG, Grisactin Ultra, Grisactin 250, Grisactin 500, Griseofulicin, Griseofulvic
Synonyms: Griseofulvin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Griseofulvin Microsize Tablets
- Dolutegravir 25 mg and 50 mg-Griseofulvin Tablets
- Dolutegravir 25 mg and 50 mg-Griseofulvin Ultramicrosize Tablets
- Dolutegravir 25 mg and 50 mg-Guaiatussin AC
- Dolutegravir 25 mg and 50 mg-Guaifen DAC
- Dolutegravir 25 mg and 50 mg-Guaifenesin AC Liquid
- Griseofulvin Microsize Oral Suspension-Dolutegravir and lamivudine
- Griseofulvin Microsize Oral Suspension-Dolutegravir and rilpivirine
- Griseofulvin Microsize Oral Suspension-Dolutegravir Sodium
- Griseofulvin Microsize Oral Suspension-Dolutegravir Sodium And Lamivudine
- Griseofulvin Microsize Oral Suspension-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Griseofulvin Microsize Oral Suspension-Dom-Etoposide